CBOE
ARK Genomic Revolution ETF (ARKG)
♥ 535 Thanks from members
The ARK Genomic Revolution ETF (ARKG) exhibits a strongly positive net sentiment (over 42% positive versus negative), driven by recent biotech valuation corrections, technical support near $34–$35, and strong institutional inflows despite historical high-beta volatility.